Evidem    
Custom Search
   
         


 

Members

Login or Join
Activities updates

 


 

Events

Hospital Sainte-Justine, Montreal
26 May 2010, Meeting of the Applied Clinical Research Unit

ISPOR Atlanta 2010, Canadian study
17 May 2010, podium session I

ISPHC Boston 2010
(PDF: 70 Kb), EVIDEM testing in Canada and South Africa
25 April 2010, podium

CADTH Halifax 2010, Application in Canada
18 April 2010, poster session 5-7 pm

University of Twente, The Netherlands
17 March 2010, EVIDEM Workshop

Canadian Institutes of Health Research, Ottawa
29 January 2010, EVIDEM Presentation

 

 


Tools and processes are freely available to members for beta-testing.

Consideration of criteria of decision that are quantifiable from a universal standpoint is performed with a MCDA Matrix to estimate the “intrinsic value” of the intervention. Consideration of other criteria (e.g., system related) is performed using a tool that integrates a list of extrinsic criteria with an ethical framework.

Framework figure

For beta-testing, a healthcare intervention is selected and a team is set to include a broad range of stakeholders. All evidence available is identified and an HTA report is developed tailored to each criterion of the MCDA Matrix. This includes synthesized evidence and quality assessments of all types of evidence (e.g., economic, clinical, epidemiological – Quality Matrix).

Applying the MCDA Matrix requires weighting all criteria and scoring the intervention, which produces an estimate of the intrinsic value of the intervention. Data or opinions on other criteria of decision are collected and integrated into the extrinsic criteria tool. Consideration of all criteria is performed during the deliberative process. The final outcome is a decision.

 

   
     
| Share
   
     

Copyright 2008-2010 EVIDEM™ Collaboration
All rights reserved / Tous droits réservés
www.evidem.org